[Antiviral treatment of chronic hepatitis B with adefovir dipivoxil].
Minami
Masahito
M
Department of Molecular Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto Prefectural University of Medicine.
Okanoue
Takeshi
T
D000225:Adenine / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D024882:Drug Resistance, Viral; D006515:Hepatitis B virus / Q000187:drug effects; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D015337:Multicenter Studies as Topic; D063065:Organophosphonates / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors; D016896:Treatment Outcome
D000998:Antiviral Agents; D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000225:Adenine; C106812:adefovir dipivoxil